CSBR News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

CS

Mkt Cap

$66.7M

Volume

1.79K

Next Earnings

N/A

Chart Financials Earnings News About Insider Filings

CSBR Stock Slips Post Q1 Earnings Despite Revenue, Margin GrowthChampions Oncology (CSBR) reported Q1 FY2027 revenues of $15.2 million, up 8.8% year-over-year, with improved margins and narrowed losses. However, the stock declined 1.8% post-earnings. The company saw strong growth in data-license revenues (up 187.1%) but faced headwinds from declining Other TOS revenues. Management emphasized continued investment in sales and marketing while pursuing funding or licensing partnerships for its Corellia platform.Zacks Investment Research · Sep 15, 2026

Champions Oncology (CSBR) Earnings TranscriptChampions Oncology reported Q3 FY2026 results with record core study revenue of $16.6 million (up 32% YoY), but overall revenue declined 3% due to absence of data revenue. The company achieved its third consecutive quarter of positive adjusted EBITDA at $575,000. Gross margins fell to 47% from 61% due to $2M in outsourced radiolabeling costs. Management expects margin improvement as work moves in-house and anticipates full-year revenue growth and positive EBITDA, with early momentum in the data business including a 6-figure deal expected to recognize in Q4.The Motley Fool · Mar 13, 2026

Insiders Buying Solid Biosciences And 2 Other StocksAlthough U.S. stocks closed mixed on Friday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. Solid Biosciences The Trade: Solid Biosciences Inc. (NASDAQ: SLDB) Director Joseph Edelman acquired a ...Benzinga · Jan 16, 2024

Insiders Buying Tilly's And 2 Other StocksAlthough U.S. stocks closed mixed on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. General American Investors The Trade: General American Investors Company, Inc. (NYSE: GAM) President and CEO ...Benzinga · Jan 10, 2024

Johnson Controls, Oracle And 3 Stocks To Watch Heading Into TuesdayWith U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Johnson Controls International plc (NYSE: JCI) to report quarterly earnings at $1.09 per share on revenue of $7.09 billion before the opening bell. Johnson Controls shares rose 1.6% to $57.50 in after-hours trading. Oracle Corporation (NYSE: ORCL) reported ...Benzinga · Dec 12, 2023

Investor Optimism Improves Further Ahead Of Inflation Data; Dow Gains For Third Straight DayThe CNN Money Fear and Greed index showed further improvement in overall market sentiment, while the index remained in the "Greed" zone on Monday. U.S. stocks closed higher on Monday, with the Dow Jones index recording its highest close since Jan. 2022. Data on consumer price index for November will be released on Tuesday, while the producer price index is scheduled for release on Wednesday. Macy's, Inc. (NYSE: M) shares jumped over 19% on Monday following a report suggesting an investor group made a $5.8 billion buyout offer for the company. Shares of The Cigna Group (NYSE: CI) climbed more than 16% on Monday after the company reportedly ended ...Benzinga · Dec 12, 2023

$5M Bet On Pyxis Oncology? Check Out These 4 Penny Stocks Insiders Are BuyingThe Dow Jones closed higher by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Champions Oncology The Trade: Champions Oncology, Inc. (NASDAQ: CSBR) CEO Ronnie Morris acquired a total of 12,382 shares an average price of $4.04. To acquire these shares, it cost around $49.97 thousand. What’s Happening: Champions Oncology posted a wider-than-expected quarterly loss. What Champions Oncology Does: Champions Oncology Inc is a ...Benzinga · Mar 22, 2023

Champions Oncology, Inc. (CSBR) Reports Q3 Loss, Tops Revenue EstimatesChampions Oncology, Inc. (CSBR) delivered earnings and revenue surprises of -200% and 2.26%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · Mar 15, 2023

Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings and Revenue EstimatesAmneal (AMRX) delivered earnings and revenue surprises of 9.52% and 4.91%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · Mar 2, 2023

ImmunoGen (IMGN) Reports Q4 Loss, Tops Revenue EstimatesImmunoGen (IMGN) delivered earnings and revenue surprises of 20.69% and 132.98%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · Mar 1, 2023

CS

CSBRChampions Oncology, Inc.

CSBR

Pay with—

Available Balance0.00

Your PositionYou don't own any CSBR yet.

Related Tickers

Earnings